Pioneering surgical blood salvage technology developed at the University of Strathclyde, Glasgow, is set to transform the way major surgery is carried out by reducing bloodclots in patients.
Hemosep is set to revolutionise the healthcare sector after gaining the CE mark and receiving Canadian national approval, following highly successful clinical trials in the world leading University of Kirikkale University Hospital in Ankara, Turkey. The device is designed to recover blood spilled during open heart and major trauma surgery and concentrate the blood cells for transfusion back to the patient. This process, known as autotransfusion, reduces the volume of donor blood required and the problems associated with transfusion reaction.
For further information click here to go to the Advancis Surgical website.
New technology to transform blood processing. Pioneering surgical blood salvage technology developed ...Read more